Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse
Authors:
Open Access
- 17 November 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (49) , 80298-80312
Abstract
We investigated the role of Smad4, a signaling molecule of the TGF-beta pathway, in T cells on the pathology of Sjögren’s syndrome (SS) in nonobese diabetic (NOD) mice, an animal model of SS. T cell-specific Smad4-deleted (Smad4fl/fl,CD4-Cre; Smad4 tKO) NOD mice had accelerated development of SS compared with wild-type (Smad4+/+,CD4-Cre; WT) NOD mice, including increased lymphocyte infiltration into exocrine glands, decreased tear and saliva production, and increased levels of autoantibodies at 12 weeks of age. Activated/memory T cells and cytokine (IFN-γ, IL-17)-producing T cells were increased in Smad4 tKO NOD mice, however the proportion and function of regulatory T (Treg) cells were not different between Smad4 tKO and WT NOD mice. Effector T (Teff) cells from Smad4 tKO NOD mice were less sensitive than WT Teff cells to suppression by Treg cells. Th17 differentiation capability of Teff cells was similar between Smad4 tKO and WT NOD mice, but IL-17 expression was increased under inducible Treg skewing conditions in T cells from Smad4 tKO NOD mice. Our results demonstrate that disruption of the Smad4 pathway in T cells of NOD mice increases Teff cell activation resulting in upregulation of Th17 cells, indicating that Smad4 in T cells has a protective role in the development of SS in NOD mice.Keywords
This publication has 51 references indexed in Scilit:
- CD8 T cell quiescence revisitedTrends in Immunology, 2012
- Requirements of transcription factor Smad-dependent and -independent TGF-β signaling to control discrete T-cell functionsProceedings of the National Academy of Sciences, 2012
- Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in miceJournal of Clinical Investigation, 2011
- Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseasesNature Reviews Immunology, 2010
- IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transferLaboratory Investigation, 2010
- Evaluation of the Transforming Growth Factor-β Activity in Normal and Dry Eye Human Tears by CCL-185 Cell BioassayCornea, 2010
- Cytokines in Sjögren's syndrome: potential therapeutic targetsAnnals of the Rheumatic Diseases, 2010
- Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell ProgramsImmunity, 2008
- ‘Yin–Yang’ functions of transforming growth factor‐β and T regulatory cells in immune regulationImmunological Reviews, 2007
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006